January 25, 2018

PRESCRIPTION OPIOID USE AND MISUSE IN AUSTRALIA: OPTIONS FOR A REGULATORY

The Therapeutic Goods Administration (TGA) has released a discussion paper titled "Prescription strong (Schedule 8) opioid use and misuse in Australia - options for a regulatory response: consultation paper."  The paper provides an overview of the challenges of balancing access to opioids for legitimate purposes, while reducing the risks associated with opioid misuse.  The TGA are seeking input from any interested person or service, and feedback can be provided until Friday 2nd of March.


Find out more here.